OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

FOSUN INTL LTD/  HK0656038673  /

Frankfurt
6/6/2024  8:21:24 AM Chg. -0.0105 Volume Bid10:08:29 AM Ask10:08:29 AM Market Capitalization Dividend Y. P/E Ratio
0.5425EUR -1.90% 0
Turnover: 0.0000		 0.5450Bid Size: 3,720 0.5665Ask Size: 3,720 5.13 bill.EUR - -
GlobeNewswire 6/1 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire 5/30 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 5/29 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 5/22 Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
GlobeNewswire 5/21 Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapano...
GlobeNewswire 5/21 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 5/17 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 5/16 Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GlobeNewswire 5/14 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 5/7 Nature’s Sunshine Reports Strong First Quarter 2024 Results
GlobeNewswire 5/7 Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Ir...
GlobeNewswire 5/6 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 5/2 Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/1 Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Ch...
GlobeNewswire 4/22 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 4/18 Intuitive Announces First Quarter Earnings
GlobeNewswire 4/18 Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
GlobeNewswire 4/7 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 3/28 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 3/25 Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate ...
GlobeNewswire 3/20 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 3/20 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 3/12 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 3/12 Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 3/11 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...